Embolic Agents: Sclerotherapy
- PMID: 38495260
- PMCID: PMC10940036
- DOI: 10.1055/s-0043-1778656
Embolic Agents: Sclerotherapy
Similar articles
-
[Application of embolic sclerotherapy for the treatment of painful venous malformation in limbs].Zhonghua Zheng Xing Wai Ke Za Zhi. 2015 Sep;31(5):352-5. Zhonghua Zheng Xing Wai Ke Za Zhi. 2015. PMID: 26930809 Chinese.
-
Use of a new embolic and sclerotic agent (GT-XIII) in endoscopic sclerotherapy.J Gastroenterol Hepatol. 1989;4 Suppl 1:181-3. J Gastroenterol Hepatol. 1989. PMID: 2519046 No abstract available.
-
Embolic and septic complications after sclerotherapy of fundic varices with cyanoacrylate.Gastrointest Endosc. 2001 Feb;53(2):228-30. doi: 10.1067/mge.2001.111561. Gastrointest Endosc. 2001. PMID: 11174302 No abstract available.
-
Complications of foam sclerotherapy.Phlebology. 2012 Mar;27 Suppl 1:46-51. doi: 10.1258/phleb.2012.012s09. Phlebology. 2012. PMID: 22312067 Review.
-
New materials in embolizations.J Cardiovasc Surg (Torino). 2016 Dec;57(6):750-757. Epub 2016 Sep 20. J Cardiovasc Surg (Torino). 2016. PMID: 27647339 Review.
References
-
- Myers K. A history of injection treatments - II sclerotherapy. Phlebology. 2019;34(05):303–310. - PubMed
-
- Borecka-Sobczak J. Sclerotherapy - from historical research to the modern and efficient method of phlebological treatment. Phlebological Rev. 2021;29(01):1–6.
-
- Mancini S, Lassueur F, Mariani F. Sclerosis of the great saphenous vein: an experimental study in humans of the sclerosing effect of an iodo-iodide solution and polidodecane (histology and electron microscopy) Phlébologie (Paris) 1991;44(02):461–468. - PubMed
-
- Urbanek T R, Piotr M, Jolanta A et al.Sclerotherapy contraindications, sequelaes, and complications - informing patients properly and objectively is required. Phlebological Rev. 2021;29:19–25.
Publication types
LinkOut - more resources
Full Text Sources